Fully remote versus hybrid supervision of pulmonary telerehabilitation in COVID-19: a randomized clinical trial

被引:0
|
作者
Vian, Bruna S. [1 ,2 ]
Ratti, Ligia S. [1 ]
Resende, Mariangela R. [3 ]
Conterno, Lucieni de O. [3 ]
Pereira, Monica C. [2 ]
机构
[1] Univ Estadual Campinas, Univ Hosp, Physiotherapy & Occupat Therapy Serv, Campinas, Brazil
[2] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Div Pneumol, Campinas, Brazil
[3] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Div Infectivol, Campinas, Brazil
基金
巴西圣保罗研究基金会;
关键词
Telerehabilitation; COVID-19; Walk test; Quality of life; 6-MINUTE WALK; STATEMENT; DISEASE; REHABILITATION; ADULTS; TESTS;
D O I
10.23736/S1973-9087.24.08634-9
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
BACKGROUND: The restrictions imposed by the COVID-19 pandemic have impeded the traditional rehabilitation process, prompting the widespread adoption of remote programs for the recovery of survivors. AIM: The aim of this study was to evaluate and compare the effectiveness of a pulmonary telerehabilitation program (PTRP) in the exclusively remote modality versus the hybrid modality (remote and face-to-face) in patients with persistent respiratory dysfunction following hospitalization for COVID-19 pneumonia, and to compare the functional capacity of patients who participated in a PTRP with those who did not. DESIGN: A randomised, interventional, prospective clinical trial was conducted. In parallel, an observational cohort study was conducted. SETTING: Outpatient rehabilitation clinic and home-based rehabilitation program. POPULATION: Thirty patients post-COVID-19 were randomised into two groups: G1 (fully remote supervision of PTRP) or G2 (hybrid supervision of PTRP). Thirty-seven post-COVID-19 patients were followed up without participating in PTRP (non-intervention group- NIG). METHODS: Patients with persistent respiratory dysfunction and reduced functional capacity, as measured by the Six Minute Walk Test (6MWT), after hospitalization for COVID-19 pneumonia, were considered eligible for a PTRP. To assess the efficacy of the PTRP, the primary outcome (I) was distance walked on the 6MWT (6MWD) and the secondary outcome (II) was quality of life as assessed by the SF-36 questionnaire. RESULTS: Both G1 and G2 demonstrated similar improvement in 6MWD, P<0.001 and quality of life (P<0.05). The IG showed higher 6MWD than the NIG (P<0.001). The increase in 6MWD for the IG was 140.5 m, while for the NIG it was 16.8 m (P=0.002). CONCLUSIONS: The PTRP was found to be a feasible and highly effective intervention for restoring functional capacity and improving quality of life, regardless of the type of supervision. Furthermore, this functional gain was maintained over the long term. In patients with pulmonary dysfunction, participation in the PTRP improved functional capacity compared with those who were simply advised to resume physical activity during recovery. CLINICAL REHABILITATION IMPACT: Telerehabilitation has been demonstrated to be a viable and efficacious alternative to traditional inperson programs in low-income contexts.
引用
收藏
页码:141 / 153
页数:13
相关论文
共 50 条
  • [1] Pulmonary telerehabilitation in patients after severe COVID-19: comparison between fully remote versus hybrid supervision
    Vian, Bruna Scharlack
    Cavallaro Barauna Lima, Ana Lucia
    De Oliveira, Lais Bacchin
    De Figueiredo, Luciana Castilho
    Ceccato, Hugo
    Silva, Julian
    Esteves Villar, Pedro Maximink
    Couto, Evelyn Regina
    Araujo Mendes, Paulo Roberto
    Conterno, Lucieni De Oliveira
    Resende, Mariangela Ribeiro
    Ratti, Ligia Roceto
    Pereira, Monica Corso
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [2] A Hybrid-Telerehabilitation Versus a Conventional Program for Urinary Incontinence: a Randomized Trial during COVID-19 Pandemic
    Santiago, Mariana
    Cardoso-Teixeira, Pedro
    Pereira, Sofia
    Firmino-Machado, Joao
    Moreira, Susana
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2023, 34 (03) : 717 - 727
  • [3] A Hybrid-Telerehabilitation Versus a Conventional Program for Urinary Incontinence: a Randomized Trial during COVID-19 Pandemic
    Mariana Santiago
    Pedro Cardoso-Teixeira
    Sofia Pereira
    João Firmino-Machado
    Susana Moreira
    International Urogynecology Journal, 2023, 34 : 717 - 727
  • [4] From hybrid to fully remote clinical trial amidst the COVID-19 pandemic: Strategies to promote recruitment, retention, and engagement in a randomized mHealth trial
    Simmons, Leigh Ann
    Phipps, Jennifer E.
    Whipps, Mackenzie
    Smith, Paige
    Carbajal, Kathryn A.
    Overstreet, Courtney
    McLaughlin, Jennifer
    De Lombaert, Koen
    Noonan, Devon
    DIGITAL HEALTH, 2022, 8
  • [5] Completion Rate of Hybrid Videoconferencing Pulmonary Telerehabilitation During the COVID-19 Pandemic
    Candemir, Ipek
    Ergun, Pinar
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2022, 42 (06) : E100 - E103
  • [6] Effect of Respiratory Telerehabilitation on Pulmonary Function Parameters and Quality of Life in Patients with COVID-19: A Randomized Controlled Trial
    Deldar, Kolsoum
    Khodabandeloo, Farnoosh
    Kargar, Nayere
    Basiri, Reza
    Froutan, Razieh
    Mazlom, Seyed Reza
    JOURNAL OF NURSING AND MIDWIFERY SCIENCES, 2024, 11 (01)
  • [7] Therapeutic pulmonary telerehabilitation protocol for patients affected by COVID-19, confined to their homes: study protocol for a randomized controlled trial
    Juan Jose Gonzalez-Gerez
    Carlos Bernal-Utrera
    Ernesto Anarte-Lazo
    Jose Antonio Garcia-Vidal
    Jose Martin Botella-Rico
    Cleofas Rodriguez-Blanco
    Trials, 21
  • [8] Therapeutic pulmonary telerehabilitation protocol for patients affected by COVID-19, confined to their homes: study protocol for a randomized controlled trial
    Jose Gonzalez-Gerez, Juan
    Bernal-Utrera, Carlos
    Anarte-Lazo, Ernesto
    Antonio Garcia-Vidal, Jose
    Martin Botella-Rico, Jose
    Rodriguez-Blanco, Cleofas
    TRIALS, 2020, 21 (01)
  • [9] The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial
    Reiersen, Angela M.
    Mattar, Caline
    Bender Ignacio, Rachel A.
    Boulware, David R.
    Lee, Todd C.
    Hess, Rachel
    Lankowski, Alexander J.
    Mcdonald, Emily G.
    Miller, J. Philip
    Powderly, William G.
    Pullen, Matthew F.
    Rado, Jeffrey T.
    Rich, Michael W.
    Schiffer, Joshua T.
    Schweiger, Julie
    Spivak, Adam M.
    Stevens, Angela
    Vigod, Simone N.
    Agarwal, Payal
    Yang, Lei
    Yingling, Michael
    Gettinger, Torie R.
    Zorumski, Charles F.
    Lenze, Eric J.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (08):
  • [10] Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial
    Said, Amira S. A.
    Hussein, Raghda R. S.
    Khalil, Doaa Mahmoud
    Fahmy, Alzhraa M.
    Hassanein, Ahmed H. A.
    Abdelaty, Lamiaa N.
    PHARMACY PRACTICE-GRANADA, 2023, 21 (01):